Many celebrities in India have been vocal about the benefits of cord blood stem cell banking. Not just movie stars, but well-known personalities from different fields have been offering their support to this life-saving procedure.
- According to a YES Bank report, the biotech market in India is expected to reach US$8 billion by next year. However, ethical issues, lack of awareness and legislation have deterred the growth of stem cell preservation in India
Celebrities are being roped in by private cord blood banks to create more awareness for this procedure. For instance, Aishwarya Rai Bachchan, a world famous movie star has been lending her name and support to this life-saving process. She is one of the many celebrities in India, who chose to get their baby’s cord blood cells preserved for future use.
At a recently held event, she emphasized on the need to educate expectant parents on the importance of this therapy. According to her, this is the best gift parents can give to their child because it secures the baby’s future health against some serious diseases. Aishwarya is the goodwill ambassador for stem cell banking in India and she hopes that advancing research in this field will surely increase the benefits of cord blood preservation in the future.
Another well-known celebrity who has been promoting this therapy in India is Lisa Ray. The actress was diagnosed with multiple myeloma a few years back. This is a cancer of the white blood cells, also known as plasma cells. She went in for this therapy and claims that it proved to be highly beneficial in her treatment.
Since her recovery, Lisa has been advocating the advantages and use of this therapy. According to her, stem cells are playing a vital role in modern medicine today. They are being used to cure various medical conditions and very soon, these life-saving cells will become useful in treatment of more diseases.
Once in a lifetime opportunity:
Preservation of these cells is a wonderful, once-in-a-lifetime opportunity for parents. They must take advantage of this process to offer protection to their baby. The cells can renew an individual’s health and life once they are administered to the patient intravenously. They can trigger the body’s natural repair processes by increasing blood flow to diseased areas and reducing inflammation.
According to medical experts, cell banking is a better choice than life insurance because it can help treat diseases and extend life. Clinical trials are underway to use the cells for creating nerve cells to treat Parkinson’s disease. Doctors are also trying to use them for treating spinal cord injuries, brain tumours, Alzheimer’s disease, cerebral palsy, autism and even heart failure.
This concept is thriving in the Western countries. Even developing countries like China and India are emerging as the leading market for biotechnology in Asia. In the last five years, the Biotech market has tripled in India and by 2015; it is expected to reach the market size of USD 8 billion.